TriSalus Life Sciences, Inc. TLSI Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s restricted cash?
- TriSalus Life Sciences, Inc. (TLSI) reported restricted cash of $400K in Q4 2025.
- How has TriSalus Life Sciences, Inc.'s restricted cash changed year-over-year?
- TriSalus Life Sciences, Inc.'s restricted cash increased by 14.3% year-over-year, from $350K to $400K.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s restricted cash?
- Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s restricted cash has grown at a 17.0% compound annual growth rate (CAGR), from $250K to $400K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.